Treatment with AT1 receptor blocker restores diabetes-induced alterations in intracellular Ca2+ transients and contractile function of rat myocardium


Ozdemir S., UĞUR M., GÜRDAL H., TURAN B.

Archives of Biochemistry and Biophysics, cilt.435, sa.1, ss.166-174, 2005 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 435 Sayı: 1
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1016/j.abb.2004.11.027
  • Dergi Adı: Archives of Biochemistry and Biophysics
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.166-174
  • Anahtar Kelimeler: heart, candesartan, type-I diabetes, intracellular calcium, action potential, protein kinise C, ANGIOTENSIN-II, VENTRICULAR MYOCYTES, SARCOPLASMIC-RETICULUM, K+ CURRENTS, POTASSIUM CURRENTS, HEART, CARDIOMYOPATHY, OVEREXPRESSION, DYSFUNCTION, INHIBITION
  • Lokman Hekim Üniversitesi Adresli: Hayır

Özet

We investigated the effect of treatment with an angiotensin II receptor blocker, candesartan-cilexetil, on the mechanical and electrophysiological properties of cardiomyocytes isolated from streptozotocin-induced diabetic (STZ) rats. Contractile activity and electrophysiological properties were measured in papillary muscle and ventricular cardiomyocytes from normoglycemic and STZ-induced diabetic rats given vehicle or 5 mg/kg/day candesartan-cilexetil for 4 weeks. Alterations in the kinetics of contractile activity and intracellular Ca2+ transients were observed as well as a typical prolongation of action potential duration and significant decrease of potassium currents in diabetic rat heart preparations. Candesartan-cilexetil treatment recovered significantly prolonged action potential and depressed potassium currents in diabetic rats. It was also shown that treatment with AT1 blocker restored altered kinetics of both the Ca2+ transients in cardiomyocytes and the contractile activity in papillary muscle strips of diabetic rats. We also showed that incubation of cardiomyocytes from diabetic rats with a protein kinase C (PKC) inhibitor bisindolylmaleimide I (BIM) had a similar effect to candesartan treatment on the Ca2+ transients. Thus, angiotensin II receptor blockade protects the heart from the development of cellular alterations typically related with diabetes, and this action of AT 1 receptors seems to be related with the activity of PKC. © 2004 Elsevier Inc. All rights reserved.